Pozzo family could sell Udinese after 39 years
Serie A side Udinese find themselves in the middle of an ownership change and the Pozzo family is now looking at selling the club.
La Gazzetta dello Sport have reported that the negotiations for the sale are being conducted by Gino Pozzo, who currently lives in Italy after having lived in London for many years. He heads the club's market strategies and talks are ongoing with a American entrepreneurs, who have a New York fund behind them.
Advertisement
Talks are proceeding quickly and in the next few days, the deal could go through. Pozzos would not completely detach from the club and would remain minority shareholders.
The deal would concern only Udinese and not Watford, with the English club set to have the Italian family as the owners. It is likely that Gino Pozzo could look to sell three key players before the family sells the Friulians.
Kaustubh Pandey I GIFN
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
CRISPR Therapeutics AG (CRSP) Rises Higher Than Market: Key Facts
The latest trading session saw CRISPR Therapeutics AG (CRSP) ending at $42.94, denoting a +2.02% adjustment from its last day's close. The stock outperformed the S&P 500, which registered a daily gain of 0.55%. At the same time, the Dow added 0.25%, and the tech-heavy Nasdaq gained 0.63%. Shares of the company have appreciated by 11.97% over the course of the past month, outperforming the Medical sector's gain of 3.49% and the S&P 500's gain of 6.29%. Investors will be eagerly watching for the performance of CRISPR Therapeutics AG in its upcoming earnings disclosure. On that day, CRISPR Therapeutics AG is projected to report earnings of -$1.54 per share, which would represent a year-over-year decline of 3.36%. At the same time, our most recent consensus estimate is projecting a revenue of $5.89 million, reflecting a 1032.88% rise from the equivalent quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$5.54 per share and revenue of $39.95 million, indicating changes of -27.65% and +7.06%, respectively, compared to the previous year. It's also important for investors to be aware of any recent modifications to analyst estimates for CRISPR Therapeutics AG. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, there's been a 1.68% fall in the Zacks Consensus EPS estimate. CRISPR Therapeutics AG is currently a Zacks Rank #3 (Hold). The Medical - Biomedical and Genetics industry is part of the Medical sector. At present, this industry carries a Zacks Industry Rank of 76, placing it within the top 31% of over 250 industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CRISPR Therapeutics AG (CRSP) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Geek Vibes Nation
34 minutes ago
- Geek Vibes Nation
How ChatGPT Bots Handle Client DMs While I Sleep – And Land Me New Deals
A good fit Ready to start Needing more info' This prompt works with DM automation tools that support branching logic. I collect info while I sleep – and wake up knowing which leads are warm. Claude Prompt #6 – Turn Chat Transcripts Into CRM Notes Prompt: 'Summarize this DM chat into 3 bullet points for my CRM: Who they are What they need How to follow up' This is huge when you're juggling 20 conversations. Claude acts like a personal assistant that cleans up your notes, flags key info, and saves it to Notion, Airtable, or whatever you use. AI DM Bot Comparison Use Case Best Model Why It Works Warm intro DM ChatGPT Fast, friendly, low-friction copy Deep context follow-up Claude Reads nuance and builds trust FAQ automation ChatGPT Clear, reusable, scalable replies Lead qualification Claude Detects readiness, helps filter CRM note generation Claude Great for summarizing long convos The Real Win – Focus on Closing, Not Replying Since I implemented this ChatGPT + Claude + Chatronix setup, I spend less time chasing leads and more time closing deals. I don't lose prospects because I replied too late. I don't drop the ball on follow-ups. And I don't miss qualified leads buried in my DMs. It's not about automating relationships – it's about automating friction so real connection can happen. Want your DMs to work while you rest? ✅ Visit Chatronix and set up your dream AI sales assistant – without hiring anyone. Emily Henry writes for UKWritings Reviews and Write My Research Paper . She writes articles on many subjects including writing great resumes. Emily is also an editor at State Of Writing .
Yahoo
2 hours ago
- Yahoo
OpenAI's open model is delayed
The release of OpenAI's first open model in years will be delayed until later this summer, CEO Sam Altman announced in a post on X on Tuesday. Altman said the open model would be released sometime after June. "We are going to take a little more time with our open-weights model, i.e. expect it later this summer but not June," he wrote. "Our research team did something unexpected and quite amazing and we think it will be very very worth the wait, but needs a bit longer." OpenAI was targeting an early summer release date for its open model, which is slated to have similar "reasoning" capabilities to OpenAI's o-series of models. OpenAI aims for its open model to top the performance of other open reasoning models, such as DeepSeek's R1. In the months since OpenAI first announced its intent to release an open model, the space has become more competitive. On Tuesday, Mistral — another AI lab that often releases open models — released its first family of AI reasoning models, called Magistral. In April, the Chinese AI lab Qwen released a family of hybrid AI reasoning models that can switch off between taking time to "reason" through problems and also giving traditional, quick responses. Beyond increasing its performance on benchmarks, OpenAI has also considered adding several complex features to its open AI model to make it more competitive. TechCrunch previously reported that OpenAI leaders have discussed enabling the open AI model to connect to the company's cloud-hosted AI models for complex queries. However, it's unclear if these features will make it into the final open model. The release of OpenAI's open model seems to be important for the company's relationship with researchers and developers. Altman has previously said that OpenAI has landed on the "wrong side of history" when it comes to open sourcing its models. To rectify that image, the company faces immense pressure to release an open model that is competitive with the industry's best open offerings. This article originally appeared on TechCrunch at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
